CORZZ
Income statement / Annual
Last year (2024), Core Scientific, Inc. Tranche 2 Warrants's total revenue was $510.67 M,
an increase of 1.65% from the previous year.
In 2024, Core Scientific, Inc. Tranche 2 Warrants's net income was -$1.32 B.
See Core Scientific, Inc. Tranche 2 Warrants,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$510.67 M |
$502.40 M |
$640.31 M |
$544.48 M |
$60.32 M |
$59.52 M |
| Cost of Revenue |
$389.60 M
|
$378.94 M
|
$631.91 M
|
$305.62 M
|
$50.93 M
|
$49.00 M
|
| Gross Profit |
$121.07 M
|
$123.46 M
|
$8.40 M
|
$238.86 M
|
$9.39 M
|
$10.53 M
|
| Gross Profit Ratio |
0.24
|
0.25
|
0.01
|
0.44
|
0.16
|
0.18
|
| Research and Development Expenses |
$11.83 M
|
$7.18 M
|
$26.96 M
|
$7.67 M
|
$5.27 M
|
$5.48 M
|
| General & Administrative Expenses |
$110.45 M
|
$93.91 M
|
$213.28 M
|
$60.49 M
|
$14.55 M
|
$13.78 M
|
| Selling & Marketing Expenses |
$9.97 M
|
$7.02 M
|
$12.73 M
|
$4.06 M
|
$1.77 M
|
$2.83 M
|
| Selling, General & Administrative Expenses |
$120.42 M
|
$100.93 M
|
$226.01 M
|
$64.55 M
|
$10,400.00
|
$16.61 M
|
| Other Expenses |
$8.02 M
|
$6.39 M
|
-$192.09 M
|
-$16.05 M
|
-$110,000.00
|
$0.00
|
| Operating Expenses |
$140.27 M
|
$114.50 M
|
$252.97 M
|
$72.22 M
|
$10,400.00
|
$22.21 M
|
| Cost And Expenses |
$529.87 M
|
$493.44 M
|
$884.89 M
|
$377.84 M
|
$10,400.00
|
$71.21 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$235,000.00
|
| Interest Expense |
$37.07 M
|
$86.24 M
|
$96.83 M
|
$44.35 M
|
$4.44 M
|
$235,000.00
|
| Depreciation & Amortization |
$120.12 M
|
$96.45 M
|
$226.09 M
|
$33.36 M
|
$9.40 M
|
$6.12 M
|
| EBITDA |
-$1.16 B |
-$63.12 M |
-$1.84 B |
$167.61 M |
-$10,400.00 |
-$4.64 M |
| EBITDA Ratio |
-2.27
|
-0.13
|
-0.03
|
0.37
|
-0
|
-0.08
|
| Operating Income Ratio |
-0.04
|
0.02
|
-0.38
|
0.31
|
-0
|
-0.18
|
| Total Other Income/Expenses Net |
-$1.29 B
|
-$254.77 M
|
-$53.86 M
|
-$68.42 M
|
-$5.88 M
|
-$235,000.00
|
| Income Before Tax |
-$1.31 B
|
-$245.80 M
|
-$2.16 B
|
$63.08 M
|
-$10,400.00
|
-$11.92 M
|
| Income Before Tax Ratio |
-2.57
|
-0.49
|
-3.38
|
0.12
|
-0
|
-0.2
|
| Income Tax Expense |
$859,000.00
|
$683,000.00
|
-$17.09 M
|
$15.76 M
|
-$4.97 M
|
$0.00
|
| Net Income |
-$1.32 B
|
-$246.49 M
|
-$2.15 B
|
$47.31 M
|
-$10,400.00
|
-$11.92 M
|
| Net Income Ratio |
-2.58
|
-0.49
|
-3.35
|
0.09
|
-0
|
-0.2
|
| EPS |
-5.14 |
-0.65 |
-6.3 |
0.23 |
-0.0002 |
-0.12 |
| EPS Diluted |
-5.14 |
-0.65 |
-6.3 |
0.2 |
-0.0002 |
-0.12 |
| Weighted Average Shares Out |
$255.83 M
|
$379.86 M
|
$340.65 M
|
$207.26 M
|
$43.13 M
|
$98.68 M
|
| Weighted Average Shares Out Diluted |
$255.83 M
|
$379.86 M
|
$340.65 M
|
$233.31 M
|
$43.13 M
|
$98.68 M
|
| Link |
|
|
|
|
|
|
